Loading…

Disease Activity in Psoriatic Arthritis : Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World

Objective. To compare, “in a real world,” the performance of the most common composite activity indices in a cohort of PsA patients. Methods. A total of 171 PsA patients were involved. The following variables were evaluated: peripheral joint assessment, patient reported of pain, physician and patien...

Full description

Saved in:
Bibliographic Details
Published in:BioMed research international 2014-01, Vol.2014 (2014), p.1-12
Main Authors: Salaffi, Fausto, Ciapetti, Alessandro, Carotti, Marina, Gasparini, Stefania, Gutierrez, Marwin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c527t-532169782b48d20cd09787e4d74a889e80e987520dab4822be3bf0860245a1013
cites cdi_FETCH-LOGICAL-c527t-532169782b48d20cd09787e4d74a889e80e987520dab4822be3bf0860245a1013
container_end_page 12
container_issue 2014
container_start_page 1
container_title BioMed research international
container_volume 2014
creator Salaffi, Fausto
Ciapetti, Alessandro
Carotti, Marina
Gasparini, Stefania
Gutierrez, Marwin
description Objective. To compare, “in a real world,” the performance of the most common composite activity indices in a cohort of PsA patients. Methods. A total of 171 PsA patients were involved. The following variables were evaluated: peripheral joint assessment, patient reported of pain, physician and patient assessments of disease activity, patient general health status, dactylitis digit count, Leeds Enthesitis Index, Health Assessment Questionnaire (HAQ), physical and mental component summary score of the Medical Outcome Survey (SF-36), Psoriasis Area and Severity Index (PASI), Dermatology Life Quality Index, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR). To measure the disease activity, the Disease Activity Score (DAS28-ESR and DAS28-CRP), Simple Disease Activity Index (SDAI), Composite Psoriatic Disease Activity Index (CPDAI), disease activity in psoriatic arthritis (DAPSA), and Psoriatic Arthritis Disease Activity Score (PASDAS) have been calculated. The criteria for minimal disease activity (MDA) and remission were applied as external criterion. Results. The ROC were similar in all the composite measures. Only the CPDAI showed less discriminative ability. There was a high degree of correlation between all the indices (P
doi_str_mv 10.1155/2014/528105
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4055291</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A427023436</galeid><sourcerecordid>A427023436</sourcerecordid><originalsourceid>FETCH-LOGICAL-c527t-532169782b48d20cd09787e4d74a889e80e987520dab4822be3bf0860245a1013</originalsourceid><addsrcrecordid>eNqN0stu1DAUBuAIgWhVumINssQGgYb6GjtdII2GW6VKIK5Ly2OfdFxl7MF2BvocvDAOU4bLBrJJnHz-bZ-cprlL8BNChDihmPATQRXB4kZzSBnhs5ZwcnP_zNhBc5zzJa6XIi3u2tvNAeVdK5kUh823Zz6DyYDmtvitL1fIB_Qmx-RN8RbNU1klX3xGp2gR1xuTfI4BxR6VFaA61ya_9qHaLaCF2Rg7RZjgqg65pNEW9NEM3k2v66x3_uuPnJh9AXQWnLeQpyUNegtmQJ9iGtyd5lZvhgzH1_ej5sOL5-8Xr2bnr1-eLebnMyuoLDPBKGk7qeiSK0exdbgOJHAnuVGqA4WhU1JQ7EwVlC6BLXusWky5MAQTdtQ83eVuxuUanIVQkhn0ph7JpCsdjdd_fgl-pS_iVnMsBO2mgIfXASl-HiEXva4VgWEwAeKYNRFtq4SUnfoPygmTWHa80gd_0cs4plArMSnZUV5_7S91YQbQPvSxbtFOoXrOqcSUcdZW9XinbIo5J-j3pyNYTw2kpwbSuwaq-v7vBdnbn-1SwaMdWPngzBf_j7R7OwyVQG_2mEulhGLfAXvc1S4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1547924231</pqid></control><display><type>article</type><title>Disease Activity in Psoriatic Arthritis : Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World</title><source>Wiley Online Library Open Access</source><source>Publicly Available Content Database</source><creator>Salaffi, Fausto ; Ciapetti, Alessandro ; Carotti, Marina ; Gasparini, Stefania ; Gutierrez, Marwin</creator><contributor>Nanki, Toshihiro</contributor><creatorcontrib>Salaffi, Fausto ; Ciapetti, Alessandro ; Carotti, Marina ; Gasparini, Stefania ; Gutierrez, Marwin ; Nanki, Toshihiro</creatorcontrib><description>Objective. To compare, “in a real world,” the performance of the most common composite activity indices in a cohort of PsA patients. Methods. A total of 171 PsA patients were involved. The following variables were evaluated: peripheral joint assessment, patient reported of pain, physician and patient assessments of disease activity, patient general health status, dactylitis digit count, Leeds Enthesitis Index, Health Assessment Questionnaire (HAQ), physical and mental component summary score of the Medical Outcome Survey (SF-36), Psoriasis Area and Severity Index (PASI), Dermatology Life Quality Index, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR). To measure the disease activity, the Disease Activity Score (DAS28-ESR and DAS28-CRP), Simple Disease Activity Index (SDAI), Composite Psoriatic Disease Activity Index (CPDAI), disease activity in psoriatic arthritis (DAPSA), and Psoriatic Arthritis Disease Activity Score (PASDAS) have been calculated. The criteria for minimal disease activity (MDA) and remission were applied as external criterion. Results. The ROC were similar in all the composite measures. Only the CPDAI showed less discriminative ability. There was a high degree of correlation between all the indices (P&lt;0.0001). The highest correlations were between DAPSA and SDAI (rho = 0.996) and between DAPSA and DAS28-CRP (rho = 0.957). CPDAI, DAPSA, and PASDAS had the most stringent definitions of remission and MDA category. DAS28-ESR and DAS28-CRP had the highest proportions in remission and MDA. Conclusions. Although a good concurrent validity and discriminant capacity of six disease activity indices were observed, the proportions of patients classified in the disease activity levels differed. In particular, the rate of patients in remission was clearly different among the respective indices.</description><identifier>ISSN: 2314-6133</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2014/528105</identifier><identifier>PMID: 24967375</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Puplishing Corporation</publisher><subject>Adult ; Arthritis, Psoriatic - pathology ; Arthritis, Psoriatic - physiopathology ; Arthritis, Psoriatic - therapy ; Care and treatment ; Clinical trials ; Comparative analysis ; Development and progression ; Diagnosis ; Female ; Humans ; Male ; Middle Aged ; Outcome and process assessment (Health Care) ; Patients ; Psoriasis ; Psoriatic arthritis ; Quality of life ; Questionnaires ; Remission (Medicine) ; Remission Induction ; Rheumatology ; Severity of Illness Index ; Skin diseases ; Sociodemographics ; Variables</subject><ispartof>BioMed research international, 2014-01, Vol.2014 (2014), p.1-12</ispartof><rights>Copyright © 2014 Fausto Salaffi et al.</rights><rights>COPYRIGHT 2014 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2014 Fausto Salaffi et al. Fausto Salaffi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2014 Fausto Salaffi et al. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c527t-532169782b48d20cd09787e4d74a889e80e987520dab4822be3bf0860245a1013</citedby><cites>FETCH-LOGICAL-c527t-532169782b48d20cd09787e4d74a889e80e987520dab4822be3bf0860245a1013</cites><orcidid>0000-0002-7995-1110 ; 0000-0002-3224-1760</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1547924231/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1547924231?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,25753,27924,27925,37012,37013,44590,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24967375$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Nanki, Toshihiro</contributor><creatorcontrib>Salaffi, Fausto</creatorcontrib><creatorcontrib>Ciapetti, Alessandro</creatorcontrib><creatorcontrib>Carotti, Marina</creatorcontrib><creatorcontrib>Gasparini, Stefania</creatorcontrib><creatorcontrib>Gutierrez, Marwin</creatorcontrib><title>Disease Activity in Psoriatic Arthritis : Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description>Objective. To compare, “in a real world,” the performance of the most common composite activity indices in a cohort of PsA patients. Methods. A total of 171 PsA patients were involved. The following variables were evaluated: peripheral joint assessment, patient reported of pain, physician and patient assessments of disease activity, patient general health status, dactylitis digit count, Leeds Enthesitis Index, Health Assessment Questionnaire (HAQ), physical and mental component summary score of the Medical Outcome Survey (SF-36), Psoriasis Area and Severity Index (PASI), Dermatology Life Quality Index, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR). To measure the disease activity, the Disease Activity Score (DAS28-ESR and DAS28-CRP), Simple Disease Activity Index (SDAI), Composite Psoriatic Disease Activity Index (CPDAI), disease activity in psoriatic arthritis (DAPSA), and Psoriatic Arthritis Disease Activity Score (PASDAS) have been calculated. The criteria for minimal disease activity (MDA) and remission were applied as external criterion. Results. The ROC were similar in all the composite measures. Only the CPDAI showed less discriminative ability. There was a high degree of correlation between all the indices (P&lt;0.0001). The highest correlations were between DAPSA and SDAI (rho = 0.996) and between DAPSA and DAS28-CRP (rho = 0.957). CPDAI, DAPSA, and PASDAS had the most stringent definitions of remission and MDA category. DAS28-ESR and DAS28-CRP had the highest proportions in remission and MDA. Conclusions. Although a good concurrent validity and discriminant capacity of six disease activity indices were observed, the proportions of patients classified in the disease activity levels differed. In particular, the rate of patients in remission was clearly different among the respective indices.</description><subject>Adult</subject><subject>Arthritis, Psoriatic - pathology</subject><subject>Arthritis, Psoriatic - physiopathology</subject><subject>Arthritis, Psoriatic - therapy</subject><subject>Care and treatment</subject><subject>Clinical trials</subject><subject>Comparative analysis</subject><subject>Development and progression</subject><subject>Diagnosis</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Outcome and process assessment (Health Care)</subject><subject>Patients</subject><subject>Psoriasis</subject><subject>Psoriatic arthritis</subject><subject>Quality of life</subject><subject>Questionnaires</subject><subject>Remission (Medicine)</subject><subject>Remission Induction</subject><subject>Rheumatology</subject><subject>Severity of Illness Index</subject><subject>Skin diseases</subject><subject>Sociodemographics</subject><subject>Variables</subject><issn>2314-6133</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqN0stu1DAUBuAIgWhVumINssQGgYb6GjtdII2GW6VKIK5Ly2OfdFxl7MF2BvocvDAOU4bLBrJJnHz-bZ-cprlL8BNChDihmPATQRXB4kZzSBnhs5ZwcnP_zNhBc5zzJa6XIi3u2tvNAeVdK5kUh823Zz6DyYDmtvitL1fIB_Qmx-RN8RbNU1klX3xGp2gR1xuTfI4BxR6VFaA61ya_9qHaLaCF2Rg7RZjgqg65pNEW9NEM3k2v66x3_uuPnJh9AXQWnLeQpyUNegtmQJ9iGtyd5lZvhgzH1_ej5sOL5-8Xr2bnr1-eLebnMyuoLDPBKGk7qeiSK0exdbgOJHAnuVGqA4WhU1JQ7EwVlC6BLXusWky5MAQTdtQ83eVuxuUanIVQkhn0ph7JpCsdjdd_fgl-pS_iVnMsBO2mgIfXASl-HiEXva4VgWEwAeKYNRFtq4SUnfoPygmTWHa80gd_0cs4plArMSnZUV5_7S91YQbQPvSxbtFOoXrOqcSUcdZW9XinbIo5J-j3pyNYTw2kpwbSuwaq-v7vBdnbn-1SwaMdWPngzBf_j7R7OwyVQG_2mEulhGLfAXvc1S4</recordid><startdate>20140101</startdate><enddate>20140101</enddate><creator>Salaffi, Fausto</creator><creator>Ciapetti, Alessandro</creator><creator>Carotti, Marina</creator><creator>Gasparini, Stefania</creator><creator>Gutierrez, Marwin</creator><general>Hindawi Puplishing Corporation</general><general>Hindawi Publishing Corporation</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7995-1110</orcidid><orcidid>https://orcid.org/0000-0002-3224-1760</orcidid></search><sort><creationdate>20140101</creationdate><title>Disease Activity in Psoriatic Arthritis : Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World</title><author>Salaffi, Fausto ; Ciapetti, Alessandro ; Carotti, Marina ; Gasparini, Stefania ; Gutierrez, Marwin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c527t-532169782b48d20cd09787e4d74a889e80e987520dab4822be3bf0860245a1013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Arthritis, Psoriatic - pathology</topic><topic>Arthritis, Psoriatic - physiopathology</topic><topic>Arthritis, Psoriatic - therapy</topic><topic>Care and treatment</topic><topic>Clinical trials</topic><topic>Comparative analysis</topic><topic>Development and progression</topic><topic>Diagnosis</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Outcome and process assessment (Health Care)</topic><topic>Patients</topic><topic>Psoriasis</topic><topic>Psoriatic arthritis</topic><topic>Quality of life</topic><topic>Questionnaires</topic><topic>Remission (Medicine)</topic><topic>Remission Induction</topic><topic>Rheumatology</topic><topic>Severity of Illness Index</topic><topic>Skin diseases</topic><topic>Sociodemographics</topic><topic>Variables</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salaffi, Fausto</creatorcontrib><creatorcontrib>Ciapetti, Alessandro</creatorcontrib><creatorcontrib>Carotti, Marina</creatorcontrib><creatorcontrib>Gasparini, Stefania</creatorcontrib><creatorcontrib>Gutierrez, Marwin</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Complete (ProQuest Database)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Database‎ (1962 - current)</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest advanced technologies &amp; aerospace journals</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salaffi, Fausto</au><au>Ciapetti, Alessandro</au><au>Carotti, Marina</au><au>Gasparini, Stefania</au><au>Gutierrez, Marwin</au><au>Nanki, Toshihiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Disease Activity in Psoriatic Arthritis : Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2014-01-01</date><risdate>2014</risdate><volume>2014</volume><issue>2014</issue><spage>1</spage><epage>12</epage><pages>1-12</pages><issn>2314-6133</issn><eissn>2314-6141</eissn><abstract>Objective. To compare, “in a real world,” the performance of the most common composite activity indices in a cohort of PsA patients. Methods. A total of 171 PsA patients were involved. The following variables were evaluated: peripheral joint assessment, patient reported of pain, physician and patient assessments of disease activity, patient general health status, dactylitis digit count, Leeds Enthesitis Index, Health Assessment Questionnaire (HAQ), physical and mental component summary score of the Medical Outcome Survey (SF-36), Psoriasis Area and Severity Index (PASI), Dermatology Life Quality Index, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR). To measure the disease activity, the Disease Activity Score (DAS28-ESR and DAS28-CRP), Simple Disease Activity Index (SDAI), Composite Psoriatic Disease Activity Index (CPDAI), disease activity in psoriatic arthritis (DAPSA), and Psoriatic Arthritis Disease Activity Score (PASDAS) have been calculated. The criteria for minimal disease activity (MDA) and remission were applied as external criterion. Results. The ROC were similar in all the composite measures. Only the CPDAI showed less discriminative ability. There was a high degree of correlation between all the indices (P&lt;0.0001). The highest correlations were between DAPSA and SDAI (rho = 0.996) and between DAPSA and DAS28-CRP (rho = 0.957). CPDAI, DAPSA, and PASDAS had the most stringent definitions of remission and MDA category. DAS28-ESR and DAS28-CRP had the highest proportions in remission and MDA. Conclusions. Although a good concurrent validity and discriminant capacity of six disease activity indices were observed, the proportions of patients classified in the disease activity levels differed. In particular, the rate of patients in remission was clearly different among the respective indices.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Puplishing Corporation</pub><pmid>24967375</pmid><doi>10.1155/2014/528105</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-7995-1110</orcidid><orcidid>https://orcid.org/0000-0002-3224-1760</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2314-6133
ispartof BioMed research international, 2014-01, Vol.2014 (2014), p.1-12
issn 2314-6133
2314-6141
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4055291
source Wiley Online Library Open Access; Publicly Available Content Database
subjects Adult
Arthritis, Psoriatic - pathology
Arthritis, Psoriatic - physiopathology
Arthritis, Psoriatic - therapy
Care and treatment
Clinical trials
Comparative analysis
Development and progression
Diagnosis
Female
Humans
Male
Middle Aged
Outcome and process assessment (Health Care)
Patients
Psoriasis
Psoriatic arthritis
Quality of life
Questionnaires
Remission (Medicine)
Remission Induction
Rheumatology
Severity of Illness Index
Skin diseases
Sociodemographics
Variables
title Disease Activity in Psoriatic Arthritis : Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T08%3A52%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Disease%20Activity%20in%20Psoriatic%20Arthritis%20:%20Comparison%20of%20the%20Discriminative%20Capacity%20and%20Construct%20Validity%20of%20Six%20Composite%20Indices%20in%20a%20Real%20World&rft.jtitle=BioMed%20research%20international&rft.au=Salaffi,%20Fausto&rft.date=2014-01-01&rft.volume=2014&rft.issue=2014&rft.spage=1&rft.epage=12&rft.pages=1-12&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2014/528105&rft_dat=%3Cgale_pubme%3EA427023436%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c527t-532169782b48d20cd09787e4d74a889e80e987520dab4822be3bf0860245a1013%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1547924231&rft_id=info:pmid/24967375&rft_galeid=A427023436&rfr_iscdi=true